Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review

Angela van Baardwijk*, Wolfgang A. Tome, Wouter van Elmpt, Soren M. Bentzen, Bart Reymen, Rinus Wanders, Ruud Houben, Michel Öllers, Philippe Lambin, Dirk De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)145-149
JournalRadiotherapy and Oncology
Issue number2
Publication statusPublished - Nov 2012


  • Stereotactic body radiation
  • Lung cancer
  • Stage I
  • SABR
  • SBRT
  • Modelling

Cite this